is wegovy a glp-1 drug Arrival of weight-loss pill new headache for food makers Medicare Will Not Cover GLP-1
Description
Simms-Williams N, Treves N, Yin H, et al
Abbreviations ADA: American Diabetes Association CV: Cardiovascular CVOTs: Cardiovascular outcome trials GLP-1RA: Glucagon-like peptide-1 receptor agonists HR: Hazard ratios MACE: Major cardiovascular events SGLT-2i: Sodiumglucose transporter-2 inhibitors T2DM: Type 2 diabetes mellitus References Giugliano D, Maiorino MI, Longo M, Bellastella G, Chiodini P, Esposito K
The lower rate of non-CV deaths was because of lower infectious deaths, in particular COVID-19related deaths, suggesting that semaglutide has a favorable outcome in terms of mortality across a broad population of patients with CV disease and obesity (88)
Semaglutide, Dulaglutide, Liraglutide, and Tirzepatide dominate the GLP-1 agonist market
Since weight loss is not the intended use of Ozempic, there are no studies on how long to use it for this treatment
novembre 2022;131(5):3729
